Prognostic utility of serum free light chain ratios and heavy-light chain ratios in multiple myeloma in three PETHEMA/GEM phase III clinical trials | PLOS ONE
Frontiers | Game of Bones: How Myeloma Manipulates Its Microenvironment
Light Chain Myeloma: Symptoms, Treatment, Outlook, More
Multiple myeloma - The Lancet
Frontiers | Serum Free Immunoglobulins Light Chains: A Common Feature of Common Variable Immunodeficiency?
The use of immunoglobulin light chain assays in the diagnosis of paraprotein-related kidney disease - Kidney International
Novel Prognostic Modalities in Multiple Myeloma | IntechOpen
Multiple Myeloma | American Society of Nephrology
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia
Multiple Myeloma for the Primary Care Provider: A Practical Review to Promote Earlier Diagnosis Among Diverse Populations - The American Journal of Medicine
Multiple myeloma - The Lancet
Multiple Myeloma: Diagnosis and Treatment - Mayo Clinic Proceedings
Follow-up of IgD-κ multiple myeloma by monitoring free light chains and total heavy chain IgD: A case report
Multiple Myeloma: Practice Essentials, Pathophysiology, Etiology
Multiple myeloma with central nervous system relapse | Haematologica
Types of Multiple Myeloma | International Myeloma Foundation
Light chain only variant of proliferative glomerulonephritis with monoclonal immunoglobulin deposits is associated with a high detection rate of the pathogenic plasma cell clone - Kidney International
Overview of Multiple Myeloma - CancerConnect
Prognostic Value of Serum Free Light Chains Measurements in Multiple Myeloma Patients | PLOS ONE
Cureus | Light-Chain Multiple Myeloma: A Diagnostic Challenge
Multiple Myeloma: Causes, First Signs, Symptoms, Diagnosis, Stages & Survival Rate
Multiple Myeloma: Diagnosis and Treatment
Stage 3 multiple myeloma: Life expectancy and outlook
Cureus | Light-Chain Multiple Myeloma: A Diagnostic Challenge
Multiple Myeloma: Navigating the First 90 Days - CONQUER: the patient voice
